Philip Chui

I am a corporate and capital markets lawyer in our corporate finance group resident in Hong Kong, with experience also working in the London office. My practice focuses on a wide variety of capital markets, mergers and acquisitions and other general corporate matters. Prior to joining Bird & Bird, I served as an associate in the Hong Kong office of another leading international law firm.

I regularly represent issuers and underwriters in relation to initial public offerings on the Hong Kong Stock Exchange, as well as mergers and acquisitions and post-listing compliance matters. I also advise clients in private equity and venture capital transactions. My clients include Hong Kong Stock Exchange listed companies, Chinese state owned enterprises, financial institutions, and companies across a multitude of industries.

I graduated from the London School of Economics and Political Science with a Bachelor of Laws and then obtained a Master of Laws from Georgetown University. I am dual qualified as an attorney in New York and as a solicitor in Hong Kong.

• Advising Wise Ally International Holdings Limited, an electronics manufacturing service (EMS) provider offering full turnkey solutions with particular focus in consumer electronic products, on its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. (Hong Kong)
• Advising Hong Kong Johnson Holdings Co, Ltd., a leading environmental hygiene service provider providing a wide range of environmental hygiene services in Hong Kong, on its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. (Hong Kong)
• Advising China Shanshui Cement Group Limited on its issuance of convertible bonds in the aggregate principal amount of US$210,900,000 to Cithara Global Multi-Strategy SPC – CMB Chung Wai Greater China Alpha Strategy SP. (Hong Kong)
• Advising a consortium of investors in its investment in Sorrento Therapeutics, Inc. (NASDAQ: SRNE) by way of purchase of convertible notes and warrants. (Hong Kong; experience gained prior to joining Bird & Bird)
• Advising a consortium of Taiwan-based minority shareholders in the privatisation of Actions Semiconductor, a Nasdaq listed PRC integrated platform solutions provider. (Hong Kong; experience gained prior to joining Bird & Bird)
• Advising Shenzhen Blue Ocean Development Fund Management Company, as general partner, and its affiliated funds in its provision of mezzanine financing to Golden Meditech Holdings, a Hong Kong listed healthcare company, for the privatisation of China Cord Blood Corporation, an NYSE listed PRC cord blood banking business, and the related exit transactions. (Hong Kong; experience gained prior to joining Bird & Bird)
• Advising Shenzhen Blue Ocean Development Fund Management Company, as general partner, and its affiliated funds in its proposed provision of mezzanine financing for the privatisation of Concord Medical Services, an NYSE listed cancer treatment services provider in the PRC and Singapore. (Hong Kong; experience gained prior to joining Bird & Bird)
• Advising Liberum Capital Limited in its role as the nomad and sole bookrunner on the £15m placing and open offer by Hornby PLC. (London)
• Advising Canaccord Genuity in its role as the nominated adviser, sole broker and bookrunner in respect of a £12m placing and debt restructuring by Woodbois Limited (London)
• Advising Canaccord Genuity in its role as the nominated adviser, jointbroker and bookrunner in respect of a £8 million placing by Gresham House PLC. (London)
• Advising Columbia Lake Partners, a leading growth debt lender, in relation to numerous growth debt transitions. (London)

• Corporate